Chemical Industry FDA Approves Asahi Kasei Therapeutics’ Hovilpri (Pritelivir) for Refractory Herpes Simplex Virus in Immunocompromised Adults WASHINGTON, D.C. — In a landmark regulatory milestone for infectious disease management, the US Food… Suro SenenOctober 13, 2026
